Joseph P. O'Connell
2019 - Odonate Therapeutics
In 2019, Joseph P. O'Connell earned a total compensation of $2M as Chief Medical Officer at Odonate Therapeutics, a 37% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $152,800 |
|---|---|
| Option Awards | $1,434,630 |
| Salary | $363,900 |
| Other | $29,238 |
| Total | $1,980,568 |
O'Connell received $1.4M in option awards, accounting for 72% of the total pay in 2019.
O'Connell also received $152.8K in non-equity incentive plan, $363.9K in salary and $29.2K in other compensation.
Rankings
In 2019, Joseph P. O'Connell's compensation ranked 5,972nd out of 13,971 executives tracked by ExecPay. In other words, O'Connell earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,972 out of 13,971 | 57th |
Division Manufacturing | 2,238 out of 5,701 | 61st |
Major group Chemicals And Allied Products | 808 out of 2,200 | 63rd |
Industry group Drugs | 682 out of 1,886 | 64th |
Industry Pharmaceutical Preparations | 503 out of 1,398 | 64th |
Source: SEC filing on May 15, 2020.
O'Connell's colleagues
We found two more compensation records of executives who worked with Joseph P. O'Connell at Odonate Therapeutics in 2019.
News
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2020 pay falls 31% to $1.4M
June 1, 2021
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2019 pay jumps 37% to $2M
May 15, 2020
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2018 pay jumps 465% to $1.4M
June 24, 2019